All Cases

Biopharma

Developed a value proposition for an EGFR-targeting biologic intended to be marked by a large international pharmaceutical company to present to IMSS in Mexico

Physician targeting by field force based on recent cancer diagnoses 

Knowledge management system design for launch and go-to-market excellence

Disease area factbook creation for a peri-launch Hem-Onc asset

Simulated pricing discount expectations and business impact of four successive label expansions of a blockbuster oncology franchise 

Analyzed a market entry strategy for a large, global pharmaceutical company to ensure it aligned with expected capacity and could be supported by its expected economic impact

Market and patient access scenario planning for a pipeline hemophilia asset

State Medicaid coverage assessment for a novel hemophilia drug

Evaluated and refined promotional materials with robust market research methodologies

Developed a targeting approach based on identification and definition of key HCP segments to inform a go-to-market strategy